Last updated: 2026-10-02 08:39:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
DataMeds AI, Inc. (MEDS) operates in the WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES sector and is listed on NASDAQ. The stock is currently priced at $3.99, with a market capitalisation of $10.14M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.82 to $12.31. This page covers its latest market performance, valuation, price trends and company information.
$10.14M | |
$4.01 | |
$504.00 | |
$0.82 | |
$4.06 | |
19.59K | |
7.24M | |
-- | |
$12.31 | |
$0.82 | |
-- | |
-- |
DataMeds AI, Inc. (MEDS) is trading at $3.99 in pre-market trading as of 2026-10-02 08:37:00, down 1.85% ($0.07) from the previous close of $4.06
Pre-market trading shows how investors are pricing MEDS before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, DataMeds AI, Inc. (MEDS) moved from $3.83 to $3.99, representing a gain of 4.05% ($0.15).
The stock traded between $3.01 and $4.65 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 10.24 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 27.5%
MEDS is currently trading at $3.99, placing it 27.5% of the way from its 52-week low of $0.82 to its 52-week high of $12.31. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
DataMEDS AI Inc is a healthcare technology and pharmaceutical logistics company. The group simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. Its solutions provide a single, integrated platform for pharmacies, wholesale distribution, and a fulfillment network focused on Independent Pharmacies and Specialty Lite medications.
| Industry | WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of DataMeds AI, Inc. (MEDS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.